Welcome to our dedicated page for Vera Bradley SEC filings (Ticker: VRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vera Bradley, Inc. (NASDAQ: VRA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Vera Bradley is an Indiana corporation based in the Fort Wayne area, and its filings offer detailed information on governance, compensation, financing arrangements, and periodic financial results that complement the company’s press releases.
Investors can review Form 8-K current reports where Vera Bradley discloses material events such as leadership changes, executive and director compensation arrangements, amendments to its asset-based revolving credit agreement, and modifications to its shareholder rights plan. For example, recent 8-K filings describe amendments that expand collateral to include certain intellectual property, adjust permitted asset sales and sale-leaseback transactions, extend the expiration of the rights plan, and document changes in executive roles and severance agreements.
In addition to event-driven 8-Ks, Vera Bradley files periodic reports such as Form 10-K annual reports and Form 10-Q quarterly reports, which contain comprehensive financial statements, segment disclosures for Vera Bradley Direct and Vera Bradley Indirect, and management’s discussion and analysis of results. These filings explain how the company reports net revenues, gross profit, operating income or loss, and the use of non-GAAP measures alongside GAAP figures.
On Stock Titan, SEC documents are updated in near real time from EDGAR, and AI-powered summaries help explain the key points of lengthy filings, including complex credit agreement amendments, rights plan terms, and compensation disclosures. Users can also monitor filings related to equity awards and other executive arrangements that may appear in exhibits to 8-Ks or in proxy materials. This page is a centralized resource for understanding Vera Bradley’s regulatory reporting history, capital structure decisions, and governance framework through its official SEC submissions.
Vera Bradley, Inc. entered into Amendment No. 1 to its Rights Agreement with Equiniti Trust Company, LLC, as rights agent. The amendment extends the definition of the “Final Expiration Date” from October 11, 2025 to October 11, 2026.
The company announced the amendment in a press release. The change is reflected under a material modification to security holder rights and the amendment text is filed as an exhibit.
Dimensional Fund Advisors LP reported beneficial ownership of 1,343,671 shares of Vera Bradley Inc common stock, representing
Vera Bradley reported weaker sales and earnings for the fiscal periods ended August 2, 2025. For the thirteen weeks, net revenues fell 24.6% to $70.9 million and the company recorded a net loss of $(4.7) million. For the twenty-six weeks, net revenues fell 24.4% to $122.5 million and net loss was $(38.1) million, which included a $(15.2) million loss on the sale of Pura Vida reported as discontinued operations.
The company completed the sale of Creative Genius (Pura Vida) on March 31, 2025 for total consideration of $3.5 million, including contingent consideration estimated at $2.5 million. Gross profit and SG&A both declined in absolute terms, while SG&A as a percentage of sales increased due to deleveraging. Cash used in operating activities was $23.3 million for the twenty-six weeks, and the company had $10.0 million borrowings with $65.0 million availability under its credit agreement as of August 2, 2025.
Other notable items: a full valuation allowance on U.S. deferred tax assets affected the effective tax rate; the board approved a $30.0 million share repurchase program (no purchases made as of August 2, 2025); management granted material restricted stock units during the period; and the company is disputing a $4.6 million purchase price adjustment claim related to the Pura Vida sale.
Vera Bradley, Inc. filed a current report to furnish an earnings press release for its quarter ended August 2, 2025. On September 11, 2025, the company released this update on its results of operations and financial condition, which is provided as Exhibit 99.1. The company notes that the information under the earnings disclosure and exhibit sections is being furnished rather than filed, meaning it is not subject to certain liability provisions under securities laws.
Vera Bradley, Inc. (VRA) – Form 4 insider filing
Director Ian Bickley reported the award of 233,463 common shares on 07/03/2025, coded “A” for an acquisition. The filing notes the shares are restricted stock units (RSUs) subject to vesting and forfeiture; no cash consideration was paid (price $0). After the grant, Bickley’s direct beneficial ownership stands at 327,091 common shares. No derivative securities were involved and no sales were disclosed. The transaction was filed individually and does not alter any other insider’s position.
Vera Bradley CFO Martin Layding reported significant insider trading activity on June 12, 2025. Key details of the transaction include:
- Acquired 414,439 restricted stock units (RSUs) at a price of $1.87 per unit
- These RSUs are subject to vesting conditions and potential forfeiture
- Additionally owns 250 shares indirectly through the Layding Family Trust, benefiting the reporting person and his wife
The Form 4 filing, signed by attorney-in-fact Alyson Bohren on June 26, 2025, indicates a significant equity-based compensation grant to the CFO. This type of award typically serves as a long-term incentive and aligns executive interests with shareholders. The transaction was reported within the required SEC disclosure timeframe.
Vera Bradley has filed a Form 3 (Initial Statement of Beneficial Ownership) disclosing the appointment of Martin Layding as Chief Financial Officer, effective June 12, 2025. This regulatory filing represents Layding's first disclosure of securities ownership as an insider.
Key ownership details:
- Beneficially owns 250 shares of common stock indirectly through the Layding Family Trust, which benefits the reporting person and his spouse
- No derivative securities (options, warrants, etc.) reported
- Filing status: Individual filing (not joint)
The Form 3 was signed by Alyson Bohren as attorney-in-fact for Martin Layding on June 26, 2025. This filing fulfills the initial disclosure requirements under Section 16(a) of the Securities Exchange Act of 1934 for new corporate insiders.
Vera Bradley Chief Administrative Officer Mark C. Dely reported the acquisition of 128,755 restricted stock units (RSUs) on June 24, 2025. The RSUs were acquired at a price of $2.33 per unit and are subject to vesting and forfeiture conditions.
Following this transaction, Dely's direct beneficial ownership increased to 363,946 shares. The transaction was reported through Form 4 filed on June 28, 2025, and was executed in compliance with SEC regulations. The filing was signed by Alyson Bohren as attorney-in-fact for Dely.
This equity-based compensation grant suggests continued alignment between executive interests and shareholder value. The RSUs represent a significant addition to the executive's holdings, potentially indicating the company's commitment to retention and long-term performance incentives.